The undesirable resilience of the pejorative term "castrate-resistant prostate cancer".

Alsaud, Yassmeen Abu; O'Reilly, David; Shanahan, Fergus; Bambury, Richard; O'Reilly, Seamus

Alsaud, Yassmeen Abu; O'Reilly, David; Shanahan, Fergus; Bambury, Richard; O'Reilly, Seamus.

Afiliación

Alsaud YA; Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
O'Reilly D; Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
Shanahan F; Department of Medicine, University College Cork, Cork, Ireland.
Bambury R; Department of Medical Oncology, Cork University Hospital, Cork, Ireland.
O'Reilly S; Department of Medical Oncology, Cork University Hospital, Cork, Ireland. Seamus.oreilly@hse.ie.

Ir J Med Sci ; 191(3): 1459-1460, 2022 06.

Article en En | MEDLINE | ID: mdl-34247313

Asunto(s)

Neoplasias de la Próstata; Humanos; Masculino; Antígeno Prostático Específico

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Límite: Humans / Male Idioma: En Revista: Ir J Med Sci Año: 2022 Tipo del documento: Article País de afiliación: Irlanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google